BACKGROUND: Previous studies reported a higher risk of cognitive decline and dementia amongst individuals with impaired lung function. However, many did not adjust for important confounders or did not include women and non-whites. METHODS: We studied 10,975 men and women aged 47-70 years (23% African-Americans) enrolled in the Atherosclerosis Risk in Communities Study. Pulmonary function tests and a cognitive assessment, including the Delayed Word Recall, the Digit Symbol Substitution, and the World Fluency Tests, were carried out in 1990-1992. Repeated cognitive assessments were performed in 1996-1998 for the entire cohort, and in 1993-1995, and 2004-2006 in 904 eligible individuals. Dementia hospitalization was ascertained through 2005. RESULTS: In analysis adjusted for lifestyles, APOE genotype, and cardiovascular risk factors, impaired lung function was associated with worse cognitive function at baseline. No association was found between lung function and cognitive decline over time. Impaired lung function at baseline was associated with higher risk of dementia hospitalization during follow-up, particularly amongst younger individuals. The hazard ratios (95% confidence intervals) of dementia hospitalization were 1.6 (0.9, 2.8) and 2.1 (1.2, 3.7) comparing the lowest with the highest quartile of forced expiratory volume in 1 s and forced vital capacity, respectively. Presence of a restrictive ventilatory pattern, but not of an obstructive pattern, was associated with reduced cognitive scores and higher dementia risk. CONCLUSION: Reduced lung function was associated with worse performance in cognitive assessments and with an increased risk of dementia hospitalization. Future research should determine whether maintaining optimal pulmonary health might prevent cognitive impairment and dementia.
BACKGROUND: Previous studies reported a higher risk of cognitive decline and dementia amongst individuals with impaired lung function. However, many did not adjust for important confounders or did not include women and non-whites. METHODS: We studied 10,975 men and women aged 47-70 years (23% African-Americans) enrolled in the Atherosclerosis Risk in Communities Study. Pulmonary function tests and a cognitive assessment, including the Delayed Word Recall, the Digit Symbol Substitution, and the World Fluency Tests, were carried out in 1990-1992. Repeated cognitive assessments were performed in 1996-1998 for the entire cohort, and in 1993-1995, and 2004-2006 in 904 eligible individuals. Dementia hospitalization was ascertained through 2005. RESULTS: In analysis adjusted for lifestyles, APOE genotype, and cardiovascular risk factors, impaired lung function was associated with worse cognitive function at baseline. No association was found between lung function and cognitive decline over time. Impaired lung function at baseline was associated with higher risk of dementia hospitalization during follow-up, particularly amongst younger individuals. The hazard ratios (95% confidence intervals) of dementia hospitalization were 1.6 (0.9, 2.8) and 2.1 (1.2, 3.7) comparing the lowest with the highest quartile of forced expiratory volume in 1 s and forced vital capacity, respectively. Presence of a restrictive ventilatory pattern, but not of an obstructive pattern, was associated with reduced cognitive scores and higher dementia risk. CONCLUSION: Reduced lung function was associated with worse performance in cognitive assessments and with an increased risk of dementia hospitalization. Future research should determine whether maintaining optimal pulmonary health might prevent cognitive impairment and dementia.
Authors: J R Cerhan; A R Folsom; J A Mortimer; E Shahar; D S Knopman; P G McGovern; M A Hays; L D Crum; G Heiss Journal: Gerontology Date: 1998 Impact factor: 5.140
Authors: Emily B Schroeder; Verna Lamar Welch; David Couper; F Javier Nieto; Duanping Liao; Wayne D Rosamond; Gerardo Heiss Journal: Am J Epidemiol Date: 2003-12-15 Impact factor: 4.897
Authors: E J van Dijk; S E Vermeer; J C de Groot; J van de Minkelis; N D Prins; M Oudkerk; A Hofman; P J Koudstaal; M M B Breteler Journal: J Neurol Neurosurg Psychiatry Date: 2004-05 Impact factor: 10.154
Authors: Linda McGowan; Chris Dickens; Carol Percival; Jane Douglas; Barbara Tomenson; Francis Creed Journal: J Psychosom Res Date: 2004-08 Impact factor: 3.006
Authors: P H Chyou; L R White; K Yano; D S Sharp; C M Burchfiel; R Chen; B L Rodriguez; J D Curb Journal: Am J Epidemiol Date: 1996-04-15 Impact factor: 4.897
Authors: Emily Clare Duggan; Raquel B Graham; Andrea M Piccinin; Natalie D Jenkins; Sean Clouston; Graciela Muniz-Terrera; Scott M Hofer Journal: J Gerontol B Psychol Sci Soc Sci Date: 2020-04-16 Impact factor: 4.077
Authors: Pamela L Lutsey; Nemin Chen; Maria C Mirabelli; Kamakshi Lakshminarayan; David S Knopman; Keith A Vossel; Rebecca F Gottesman; Thomas H Mosley; Alvaro Alonso Journal: Am J Respir Crit Care Med Date: 2019-06-01 Impact factor: 21.405
Authors: Keiichi Sumida; Lucia Kwak; Morgan E Grams; Kunihiro Yamagata; Naresh M Punjabi; Csaba P Kovesdy; Josef Coresh; Kunihiro Matsushita Journal: Am J Kidney Dis Date: 2017-07-26 Impact factor: 8.860
Authors: Terrie Vasilopoulos; Michael D Grant; Carol E Franz; Matthew S Panizzon; Hong Xian; Rosemary Toomey; Michael J Lyons; William S Kremen; Kristen C Jacobson Journal: Behav Genet Date: 2013-01-09 Impact factor: 2.805
Authors: Terrie Vasilopoulos; William S Kremen; Michael D Grant; Matthew S Panizzon; Hong Xian; Rosemary Toomey; Michael J Lyons; Kristen C Jacobson; Carol E Franz Journal: J Epidemiol Community Health Date: 2014-10-01 Impact factor: 3.710
Authors: Paola Gilsanz; Elizabeth Rose Mayeda; Jason Flatt; M Maria Glymour; Charles P Quesenberry; Rachel A Whitmer Journal: Alzheimer Dis Assoc Disord Date: 2018 Oct-Dec Impact factor: 2.703
Authors: Regina C Sims; Roland J Thorpe; Alyssa A Gamaldo; Adrienne T Aiken-Morgan; LaBarron K Hill; Jason C Allaire; Keith E Whitfield Journal: J Aging Health Date: 2014-07-21